nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—PTGS2—bile duct cancer	0.835	1	CbGaD
Tolmetin—MPO—superior mesenteric artery—bile duct cancer	0.0913	0.708	CbGeAlD
Tolmetin—TDO2—liver—bile duct cancer	0.00652	0.0505	CbGeAlD
Tolmetin—CXCL8—pancreas—bile duct cancer	0.00564	0.0437	CbGeAlD
Tolmetin—TDO2—lymph node—bile duct cancer	0.005	0.0387	CbGeAlD
Tolmetin—CXCL8—liver—bile duct cancer	0.00359	0.0278	CbGeAlD
Tolmetin—MPO—pancreas—bile duct cancer	0.0033	0.0256	CbGeAlD
Tolmetin—PTGS2—gall bladder—bile duct cancer	0.00325	0.0252	CbGeAlD
Tolmetin—CXCL8—lymph node—bile duct cancer	0.00275	0.0213	CbGeAlD
Tolmetin—MPO—liver—bile duct cancer	0.0021	0.0163	CbGeAlD
Tolmetin—Ketorolac—PTGS2—bile duct cancer	0.00176	0.221	CrCbGaD
Tolmetin—Bromfenac—PTGS2—bile duct cancer	0.00169	0.212	CrCbGaD
Tolmetin—MPO—lymph node—bile duct cancer	0.00161	0.0125	CbGeAlD
Tolmetin—PTGS2—pancreas—bile duct cancer	0.0015	0.0116	CbGeAlD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—bile duct cancer	0.00145	0.0524	CbGpPWpGaD
Tolmetin—Lumiracoxib—PTGS2—bile duct cancer	0.00144	0.18	CrCbGaD
Tolmetin—Fenbufen—PTGS2—bile duct cancer	0.00131	0.164	CrCbGaD
Tolmetin—Suprofen—PTGS2—bile duct cancer	0.00109	0.136	CrCbGaD
Tolmetin—PTGS2—liver—bile duct cancer	0.000951	0.00738	CbGeAlD
Tolmetin—MPO—IL23-mediated signaling events—NOS2—bile duct cancer	0.000839	0.0304	CbGpPWpGaD
Tolmetin—CXCL8—Overview of nanoparticle effects—PTGS2—bile duct cancer	0.00078	0.0282	CbGpPWpGaD
Tolmetin—TDO2—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.000766	0.0277	CbGpPWpGaD
Tolmetin—PTGS1—lymph node—bile duct cancer	0.000763	0.00592	CbGeAlD
Tolmetin—PTGS2—lymph node—bile duct cancer	0.000729	0.00566	CbGeAlD
Tolmetin—Indomethacin—PTGS2—bile duct cancer	0.000692	0.0868	CrCbGaD
Tolmetin—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bile duct cancer	0.000549	0.0199	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—MMP2—bile duct cancer	0.000546	0.0197	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—ERBB2—bile duct cancer	0.000539	0.0195	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—bile duct cancer	0.000534	0.0193	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-3-mediated signaling events—EGFR—bile duct cancer	0.00051	0.0185	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—FAR2—bile duct cancer	0.000508	0.0184	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—PTGS2—bile duct cancer	0.00043	0.0156	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—NOS2—bile duct cancer	0.000428	0.0155	CbGpPWpGaD
Tolmetin—CXCL8—Overview of nanoparticle effects—IL6—bile duct cancer	0.000425	0.0154	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—GNAS—bile duct cancer	0.000411	0.0149	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—bile duct cancer	0.000401	0.0145	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—EGFR—bile duct cancer	0.000374	0.0135	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—MMP2—bile duct cancer	0.000368	0.0133	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—SMAD4—bile duct cancer	0.000363	0.0131	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—bile duct cancer	0.000359	0.013	CbGpPWpGaD
Tolmetin—PTGS1—Eicosanoid Synthesis—PTGS2—bile duct cancer	0.000357	0.0129	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—MMP2—bile duct cancer	0.000344	0.0125	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—TGFB1—bile duct cancer	0.000338	0.0122	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—IL6—bile duct cancer	0.000336	0.0122	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—PTGS2—bile duct cancer	0.00032	0.0116	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—TP53—bile duct cancer	0.000314	0.0114	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.000308	0.0112	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—HRAS—bile duct cancer	0.0003	0.0109	CbGpPWpGaD
Tolmetin—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bile duct cancer	0.000298	0.0108	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bile duct cancer	0.000288	0.0104	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—bile duct cancer	0.000285	0.0103	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—HRAS—bile duct cancer	0.000266	0.00963	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—TGFB1—bile duct cancer	0.000264	0.00956	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—IL6—bile duct cancer	0.00026	0.00941	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—MMP9—bile duct cancer	0.000259	0.00937	CbGpPWpGaD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—bile duct cancer	0.000249	0.00902	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—NRAS—bile duct cancer	0.000249	0.00901	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—IDH2—bile duct cancer	0.000248	0.00898	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—NOS2—bile duct cancer	0.000246	0.0089	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000245	0.00887	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—MMP9—bile duct cancer	0.000241	0.00872	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—IL6—bile duct cancer	0.000234	0.00848	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TP53—bile duct cancer	0.000231	0.00836	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MUC4—bile duct cancer	0.000226	0.00819	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MUC1—bile duct cancer	0.000226	0.00819	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bile duct cancer	0.000217	0.00784	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—KRAS—bile duct cancer	0.000214	0.00776	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—IDH1—bile duct cancer	0.000213	0.00772	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL6—bile duct cancer	0.000211	0.00765	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—EGFR—bile duct cancer	0.000209	0.00757	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—HRAS—bile duct cancer	0.000208	0.00753	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—IL6—bile duct cancer	0.000206	0.00745	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TGFB1—bile duct cancer	0.000199	0.00719	CbGpPWpGaD
Tolmetin—PTGS1—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000198	0.00718	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000195	0.00704	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—GNAS—bile duct cancer	0.000194	0.00702	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—IL6—bile duct cancer	0.000186	0.00673	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—HRAS—bile duct cancer	0.000182	0.00659	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—PTGS2—bile duct cancer	0.000181	0.00655	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TGFB1—bile duct cancer	0.00018	0.00652	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—IL6—bile duct cancer	0.000172	0.00621	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MUC2—bile duct cancer	0.000171	0.00621	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL6—bile duct cancer	0.000168	0.00608	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—HRAS—bile duct cancer	0.000168	0.00608	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TP53—bile duct cancer	0.000163	0.00592	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—TGFB1—bile duct cancer	0.00016	0.00578	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MMP9—bile duct cancer	0.000159	0.00574	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000157	0.00568	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL6—bile duct cancer	0.00015	0.00542	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—bile duct cancer	0.000144	0.00521	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TGFB1—bile duct cancer	0.000144	0.0052	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—SLC5A5—bile duct cancer	0.000141	0.00509	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL6—bile duct cancer	0.000132	0.00477	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.000131	0.00474	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TGFB1—bile duct cancer	0.000131	0.00473	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—EGFR—bile duct cancer	0.000128	0.00464	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.000126	0.00457	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bile duct cancer	0.000125	0.00451	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.000119	0.00432	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—bile duct cancer	0.000118	0.00428	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—GNAS—bile duct cancer	0.000118	0.00425	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—HRAS—bile duct cancer	0.000113	0.00409	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.000113	0.00408	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—bile duct cancer	0.000111	0.00401	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GNAS—bile duct cancer	0.000109	0.00396	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—FAR2—bile duct cancer	0.000109	0.00395	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL6—bile duct cancer	0.000108	0.00392	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—bile duct cancer	0.000108	0.00392	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—NOS2—bile duct cancer	0.000108	0.0039	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—bile duct cancer	0.000108	0.0039	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000103	0.00373	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL6—bile duct cancer	9.85e-05	0.00357	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	9.85e-05	0.00356	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	9.58e-05	0.00347	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—FAR2—bile duct cancer	8.67e-05	0.00314	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	8.64e-05	0.00313	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	8.17e-05	0.00296	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—NRAS—bile duct cancer	8.09e-05	0.00293	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RNF43—bile duct cancer	8.08e-05	0.00292	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	7.98e-05	0.00289	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—bile duct cancer	7.88e-05	0.00285	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—bile duct cancer	7.48e-05	0.00271	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—KRAS—bile duct cancer	6.96e-05	0.00252	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	6.95e-05	0.00252	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—bile duct cancer	6.87e-05	0.00249	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—bile duct cancer	6.85e-05	0.00248	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—GNAS—bile duct cancer	6.64e-05	0.0024	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—GNAS—bile duct cancer	6.2e-05	0.00224	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—GNAS—bile duct cancer	6.03e-05	0.00218	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	5.92e-05	0.00214	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTGS2—bile duct cancer	5.87e-05	0.00213	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	5.73e-05	0.00207	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—bile duct cancer	5.65e-05	0.00205	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	5.62e-05	0.00203	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	5.51e-05	0.00199	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	5.46e-05	0.00198	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—IDH2—bile duct cancer	5.33e-05	0.00193	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MMP2—bile duct cancer	5.18e-05	0.00188	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—bile duct cancer	5.17e-05	0.00187	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RNF43—bile duct cancer	5.05e-05	0.00183	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	4.72e-05	0.00171	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—IDH1—bile duct cancer	4.59e-05	0.00166	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IDH1—bile duct cancer	4.35e-05	0.00157	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	4.32e-05	0.00156	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—IDH2—bile duct cancer	4.23e-05	0.00153	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	3.9e-05	0.00141	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	3.82e-05	0.00138	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFBR2—bile duct cancer	3.69e-05	0.00134	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—IDH1—bile duct cancer	3.64e-05	0.00132	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	3.61e-05	0.00131	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—GNAS—bile duct cancer	3.56e-05	0.00129	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SMAD4—bile duct cancer	3.5e-05	0.00127	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	3.21e-05	0.00116	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SLC5A5—bile duct cancer	3.03e-05	0.00109	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.83e-05	0.00103	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—NRAS—bile duct cancer	2.52e-05	0.000912	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SLC5A5—bile duct cancer	2.4e-05	0.000869	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GNAS—bile duct cancer	2.35e-05	0.000851	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFBR2—bile duct cancer	2.31e-05	0.000836	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—bile duct cancer	2.3e-05	0.000831	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SMAD4—bile duct cancer	2.19e-05	0.000791	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KRAS—bile duct cancer	2.17e-05	0.000785	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ERBB2—bile duct cancer	1.96e-05	0.000708	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GNAS—bile duct cancer	1.87e-05	0.000675	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—bile duct cancer	1.84e-05	0.000667	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—bile duct cancer	1.76e-05	0.000639	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MMP9—bile duct cancer	1.68e-05	0.000607	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NOS2—bile duct cancer	1.63e-05	0.000589	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NRAS—bile duct cancer	1.49e-05	0.000539	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—bile duct cancer	1.38e-05	0.000501	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—bile duct cancer	1.36e-05	0.000491	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KRAS—bile duct cancer	1.28e-05	0.000464	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTGS2—bile duct cancer	1.26e-05	0.000457	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ERBB2—bile duct cancer	1.22e-05	0.000443	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—bile duct cancer	1.14e-05	0.000412	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—bile duct cancer	1.09e-05	0.000394	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—bile duct cancer	1.04e-05	0.000377	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NRAS—bile duct cancer	9.31e-06	0.000337	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—bile duct cancer	8.65e-06	0.000313	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—bile duct cancer	8.48e-06	0.000307	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KRAS—bile duct cancer	8.01e-06	0.00029	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—bile duct cancer	6.81e-06	0.000247	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—bile duct cancer	6.52e-06	0.000236	CbGpPWpGaD
